The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Granisetron extended-release subcutaneous injection versus palonosetron infusion for preventing chemotherapy-induced nausea and vomiting: A cost analysis.
 
Vikas Kumar
No Relationships to Disclose
 
Martin Barnes
No Relationships to Disclose
 
George Calcanes
No Relationships to Disclose
 
Michael Mosier
Consulting or Advisory Role - HERON
 
Danille Virgilio
No Relationships to Disclose
 
Jeffrey L. Vacirca
Leadership - AmerisourceBergen; Odonate Therapeutics; Spectrum Pharmaceuticals
Stock and Other Ownership Interests - Coherus Biosciences; HERON; La Jolla Pharma; Loxo; Mirati Therapeutics; Odonate Therapeutics; Spectrum Pharmaceuticals
Consulting or Advisory Role - AmerisourceBergen
Patents, Royalties, Other Intellectual Property - Odonate Therapeutics
Travel, Accommodations, Expenses - AmerisourceBergen; Odonate Therapeutics; OneOncology; Spectrum Pharmaceuticals